Impaired Mitochondrial Bioenergetics Function in Pediatric Chronic Overlapping Pain Conditions with Functional

Gisela Chelimsky1, Pippa Simpson2, Liyun Zhang2

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Center for Pediatric Neurogastroenterology, Motility, and Autonomic Disorders, Medical College of Wisconsin, Milwaukee 53226, WI, USA.

Insights

Children with chronic overlapping pain disorders (COPC) exhibit reduced mitochondrial ATP production, contributing to fatigue. Spare respiratory capacity (SRC) emerged as a key predictor of functional disability in these patients.

Area of Science:

  • Pediatric Gastroenterology
  • Mitochondrial Physiology
  • Chronic Pain Syndromes

Background:

  • Fatigue is a primary symptom in pediatric functional gastrointestinal disorders (FGID) and chronic overlapping pain disorders (COPC).
  • The underlying cause of fatigue in these conditions remains largely unknown.
  • Mitochondrial dysfunction is a potential contributor to fatigue and other symptoms.

Purpose of the Study:

  • To evaluate mitochondrial function in children diagnosed with FGID and COPC.
  • To investigate the relationship between mitochondrial energy production and the severity of fatigue and disability.
  • To identify potential biomarkers for fatigue in pediatric chronic pain conditions.

Main Methods:

  • A prospective study involving children aged 10-18 with COPC and healthy controls (HC).
  • Mitochondrial function assessed in peripheral mononuclear cells (PMC) using Seahorse XF96 Extracellular Flux Analyzer.
  • Measured parameters included basal respiration (BR), ATP-linked oxygen consumption (ATP-LC), maximal oxygen consumption rate (max R), spare respiratory capacity (SRC), and extracellular acidification rate (ECAR).
  • Statistical analyses included Mann-Whitney, Fisher's exact test, and regression tree analysis for functional disability (FDI).

Main Results:

  • COPC subjects demonstrated lower BR, ECAR, and ATP-LC rates compared to HC, indicating stressed mitochondria and reduced ATP production.
  • FGID, orthostatic intolerance, migraine, sleep disturbance, and chronic fatigue were prevalent in the COPC group.
  • Spare respiratory capacity (SRC) was the strongest predictor of functional disability, with SRC >150 associated with greater disability (p=0.021).

Conclusions:

  • Children with COPC exhibit impaired mitochondrial ATP production capacity.
  • The findings suggest potential genetic or acquired factors affecting mitochondrial function.
  • Higher SRC may indicate underutilized energy reserves or a 'brake' on mitochondrial function, correlating with increased disability.
Abstract

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
682
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
343
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
574
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
566
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
39